Clinical trials
Phase 1/2 Nasopharyngeal Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
| Completed | 8 |
| Terminated | 5 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Proton and Heavy Ion Center | 3 |
| Shanghai Junshi Bioscience Co., Ltd. | 2 |
| Sun Yat-sen University | 2 |
| Chinese Academy of Medical Sciences | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Genmab | 1 |
| Innolake Biopharm | 1 |
| Jiangsu Cancer Institute & Hospital | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 25 |
| Nasopharyngeal Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Head and Neck Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Epstein-Barr Virus Infections | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.